论文部分内容阅读
树突状细胞ｄｅｎｄｒｉｔｉｃｃｅｌｌＤＣ为基础的新型肿瘤疫苗正在临床试验中。目前的多种制备方法中，以动员人外周造血祖细胞为主要细胞来源，用血细胞分离机分离、体外加入ＧＭＣＳＦ和ＩＬ４培养扩增制备树突状细胞是一种新的制备技术，具有获得的细胞数量多、均质性好
DendriticcellDC-based novel tumor vaccines for dendritic cells are in clinical trials. In the current preparation methods, mobilizing human peripheral hematopoietic progenitor cells as the main cell source, separating with a blood cell separator, in vitro adding GMCSF and IL4 to culture and preparing dendritic cells is a new preparation technique, which has Large number of cells and good homogeneity